Healx, a U.K. startup using AI to discover new drugs for rare diseases, has raised $47 million in a Series C round of funding co-led by Europe’s Atomico and Silicon Valley-based R42. The company also said that it has received regulatory clearance to start Phase 2 clinical trials for a new drug in the U.S. […]
© 2024 TechCrunch. All rights reserved. For personal use only.
